Secondary analysis strengthens the safety of the blood thinner

Treatment with blood thinner apixaban has been associated with a lower risk of bleeding, death and hospitalization than warfarin, regardless of the history of stroke or previous blood clot, according to a secondary analysis presented today as a science at the cutting edge in the American Stroke Association International Stroke Association Conference 2020. The conference, […]